跳至主要内容
临床试验/NCT06921863
NCT06921863尚未招募不适用

Decisional Regret Following Radiotherapy Against Cancer With Poor to Excellent Prognosis

University Medical Center Goettingen0 个研究点目标入组 165 人开始时间: 2025年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
165
主要终点
Decisional Regret

研究概览

简要总结

In this prospective registry study, patients with low-, intermediate- and high-risk tumor entities as well as patients with high symptom burden of any tumor entity in palliative constellation with indication for radiation treatment are included. This radiation treatment can be applied either as 3D-conformal RT or IGRT. The duration of treatment can range from one day to several weeks. For the primary endpoint as well as the secondary clinical and other exploratory endpoints, the 3 groups will be compared in terms of DR, QoL, toxicities and treatment plan parameters

详细描述

Decisional regret and quality of life are quantified and analyzed using general linear models (e.g. linear regression models, ANOVA), taking into account covariates such as tumor stage, application of further systemic therapies, extent of the radiation area, occurrence of acute and/or late side effects. Survival time analyses and tumor control rates are evaluated using Kaplan- Meyer and Cox regression. Technical endpoints, quality of life and patient satisfaction will be described descriptively and compared between the cohorts using a mixed linear model.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for radiotherapy
  • Patient information and declaration of consent
  • Patients age ≥ 18 years

排除标准

  • previous radiotherapy in affected site or same localisation in group 1-3
  • Inability to answer the questionnaires
  • Pre-existing conditions with increased risk of acute or late toxicity (LiFraumeni, Crohn's disease, ulcerative colitis)
  • Simultaneous participation in other studies that could interfere with this study and/or participation before expiry of a required restriction period
  • Persons who are in a dependent/employment relationship with the investigator

结局指标

主要结局

Decisional Regret

时间窗: from enrollment to the end of routinely performed clinical follow-up examinations after 5 yeasr after RT start

Decisional Regret (DR) is measured by the German version of the Ottawa Decisional Regret Scale (Rühle et al. 2014) by answering the comprising 5 questions. Responses are provided on a five-point Likert scale. Decision regret is categorized as absent (0 points), mild (1-25 points) and strong (\>25 points).

Quality of Life after Radiotherapy

时间窗: from enrollment to the end of routinely performed clinical follow-up examinations after 5 yeasr after RT start

Quality of Life is measured using the 80 question comprising PRO-CTCAE questionnaire version 1.0 (Hagelstein et al 2016) , the 30 question comprising EORTC QLQC30 questionnaire version 3.0 and the PSQ-18 questionnaire (Thayaparan and Mahdi 2013). All questionnaires have been previously validated in other publications.

次要结局

未报告次要终点

研究者

发起方
University Medical Center Goettingen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. med. Stephanie Bendrich

Dr. med. Stephanie Bendrich

University Medical Center Goettingen

相似试验